deuruxolitinib
sun pharma
['rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)', 'ctp-543', 'thrive-aa2', 'deuruxolitinib', 'alopecia areata ', 'derm', 'ruxolitinib', 'concert pharma', 'sun pharma']
late-breaking phase 3 data at aad 2023 show oral investigational medicine deuruxolitinib significantly improved scalp hair regrowth in alopecia areata.
#latebreaking #phase03data #aad2023 #oralinvestigationalmedicine #deuruxolitinib #improved #scalphair #regrowth #alopeciaareata 
Non-commercial Channel;
Learning and Educational Purpose; Creating Awareness on Stock Market Information;
MORE CONTENT on Telegram: @MarketVedantA